ADVERSE REACTIONS SECTION.

ADVERSE REACTIONS. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.

PRINCIPAL DISPLAY PANEL. NDC 0143-9151-01 Rx only DihydroergotamineMesylate Injection, USP1 mg/mL For IV, IM or SC Use ONLY mL Single-Dose VialNDC 0143-9151-10 Rx onlyDihydroergotamineMesylate Injection, USP1 mg/mLFor Intramuscular, Intravenous or Subcutaneous Use ONLY 10 1 mL Single-Dose Vials. vial label. Carton.